Eloxx receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until July 5, 2022

Eloxx Pharmaceuticals, Inc.

Closing bid price of common stock below $1.00 for 30 consecutive business days as of Jan 3, 2022.
Company has until July 5, 2022 to regain compliance; may qualify for an additional 180-day grace period.
Options to cure include a reverse stock split; no assurance of regaining compliance.
Stock continues trading on Nasdaq Global Market under symbol ELOX during the cure period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.